Microglia activation plays a crucial role in neurodegenerative diseases. There are at least two distinct ways of microglia activation, the classical lipopolysaccharide (LPS) induced pathway leading to secretion of pro-inflammatory cytokines and inflammation as well as the alternative interleukin-4 (IL-4) induced pathway resulting in increased wound healing and tissue repair (Figure 1). It is known that the anti-inflammatory alternative pathway is competent to dampen the inflammatory effects of the classical microglia activation, as IL-6 and tumor necrosis factor-α (TNF-α) levels of LPS-stimulated microglia were remarkably reduced after additional excitation of the alternative activation of microglia. This effect could be achieved by the use of particular RNA binding proteins. An example for such RNA binding proteins would be tristetraprolin (TTP). TTP is binding to AU-rich elements (ARE) in the 3’ untranslated region of mRNA molecules and promotes decay of ARE-containing transcripts by directing them to the exosome for rapid mRNA degradation. The aim of the practical research course was to ascertain a possible participation of TTP in the IL-4 induced alternative activation of microglia, thereby potentially explaining the dampening effect on the inflammatory pathway.
Table of Contents
1. Introduction
2. Methods
2.1 Western Blot Analysis (WB)
2.2 RNA Isolation
2.3 Reverse-Transcription-PCR (RT-PCR)
2.4 Quantitative Real-Time PCR (qPCR)
2.5 Immunocytochemistry
3. Results and Discussion
3.1 Microglia
3.2 Astrocytes
Research Objectives and Key Topics
This report investigates the role of the RNA-binding protein tristetraprolin (TTP) in the activation pathways of microglia and astrocytes, specifically focusing on its potential involvement in regulating inflammatory responses and the influence of AMPK signaling. The study seeks to determine if TTP levels are modulated by classical (LPS) and alternative (IL-4) activation stimuli, as well as by the AMPK activator AICAR.
- Mechanisms of TTP-mediated post-transcriptional control of cytokine production.
- Differential activation pathways in microglia (classical vs. alternative).
- Impact of AMPK signaling on TTP expression and inflammatory cytokine modulation.
- Comparative analysis of TTP expression between microglia and astrocytes.
- Methodological application of Western Blotting, qPCR, and Immunocytochemistry.
Excerpt from the Book
INTRODUCTION
Microglia activation plays a crucial role in neurodegenerative diseases. There are at least two distinct ways of microglia activation, the classical lipopolysaccharide (LPS) induced pathway leading to secretion of pro-inflammatory cytokines and inflammation as well as the alternative interleukin-4 (IL-4) induced pathway resulting in increased wound healing and tissue repair (Figure 1). It is known that the anti-inflammatory alternative pathway is competent to dampen the inflammatory effects of the classical microglia activation, as IL-6 and tumor necrosis factor-α (TNF-α) levels of LPS-stimulated microglia were remarkably reduced after additional excitation of the alternative activation of microglia (Ferger et al., 2010). This effect could be achieved by the use of particular RNA binding proteins.
An example for such RNA binding proteins would be tristetraprolin (TTP). TTP is binding to AU-rich elements (ARE) in the 3’ untranslated region of mRNA molecules and promotes decay of ARE-containing transcripts by directing them to the exosome for rapid mRNA degradation (Figure 2). An exemplary indicator for TTP activity is TNF-α, a pro inflammatory cytokine which is upregulated in inflammatory processes and possesses an AU rich domain in its mRNA. Binding of TTP is leading to a decrease of TNF-α mRNA. Concurrently with a production of inflammatory cytokines, after LPS stimulation the expression of TTP is increased. However, mRNA of inflammatory cytokines is rescued from TTP mediated decay by activation of p38-MK2 kinases via LPS, leading to phosphorylation of TTP, thus recruiting 14-3-3 proteins. This family of proteins can hinder interaction of TTP with the decay machinery, resulting in a stabilization of the respective mRNA.
Summary of Chapters
1. Introduction: This chapter introduces the theoretical background of microglia activation and the regulatory function of the RNA-binding protein tristetraprolin (TTP) in inflammation.
2. Methods: This section details the experimental protocols utilized, including protein and RNA quantification techniques like Western Blotting, RT-PCR, and Immunocytochemistry.
3. Results and Discussion: This chapter presents the experimental findings regarding TTP expression levels in microglia and astrocytes under various stimulation conditions and discusses the implications of these observations.
Keywords
Microglia, Astrocytes, Neurodegenerative Diseases, Tristetraprolin, TTP, Inflammation, Lipopolysaccharide, Interleukin-4, AMPK, AICAR, Western Blot, qPCR, Immunocytochemistry, Cytokine regulation, RNA-binding proteins
Frequently Asked Questions
What is the core focus of this research report?
The report focuses on the role of tristetraprolin (TTP) in regulating inflammatory responses within microglia and astrocytes, investigating how different activation pathways affect its expression.
What are the primary themes discussed?
The central themes include the mechanism of mRNA decay by TTP, the distinction between classical and alternative microglial activation, and the modulation of TTP by AMPK signaling.
What is the main objective of the study?
The goal was to determine if TTP participates in the IL-4-induced alternative activation of microglia and to assess if the AMPK activator AICAR influences TTP expression levels.
Which scientific methods were employed?
The study utilized Western Blot analysis for protein levels, quantitative real-time PCR (qPCR) for mRNA quantification, and immunocytochemistry to observe cellular protein localization.
What is covered in the main body of the work?
The work covers the introduction to TTP-mediated post-transcriptional control, detailed experimental methods, and the presentation of data regarding TTP expression in stimulated microglia and astrocytes.
Which keywords define this work?
Key terms include microglia, astrocytes, TTP, inflammation, AMPK signaling, and post-transcriptional control.
Why were experiments conducted on astrocytes after initial microglia studies?
Due to a shortage of microglial cells, the researchers performed further experiments on astrocytes to determine if similar inflammatory regulatory mechanisms exist in these glial cells.
What conclusion did the author reach regarding TTP in astrocytes?
The author concludes that astrocytes do not exhibit detectable amounts of TTP, suggesting that they may regulate cytokine production through pathways different from those used by microglia.
What did the immunofluorescence images suggest about the anti-TTP antibody?
The images suggested a lack of specificity, as the TTP antibody signals in astrocytes were nearly identical to those of the GFAP marker, likely labeling cytoskeletal components instead of TTP.
- Quote paper
- Simon Schwörer (Author), 2012, Microglia in Neurodegenerative Diseases, Munich, GRIN Verlag, https://www.hausarbeiten.de/document/190962
